Cargando…

Tissue biomarkers of breast cancer and their association with conventional pathologic features

BACKGROUND: Tissue protein expression profiling has the potential to detect new biomarkers to improve breast cancer (BC) diagnosis, staging, and prognostication. This study aimed to identify tissue proteins that differentiate breast cancer tissue from healthy breast tissue using protein chip mass sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, L, Shibli, S, Moore, K, Elder, E E, Boyle, F M, Marsh, D J, Baxter, R C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566809/ https://www.ncbi.nlm.nih.gov/pubmed/23299531 http://dx.doi.org/10.1038/bjc.2012.552

Ejemplares similares

Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides
por: Aaltonen, K, et al.
Publicado: (2006)

Non-conventional role of haemoglobin beta in breast malignancy
por: Ponzetti, Marco, et al.
Publicado: (2017)

Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis
por: Xue, A, et al.
Publicado: (2010)

Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling
por: Atrih, A, et al.
Publicado: (2014)

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics
por: Kristiansen, G, et al.
Publicado: (2008)

Astronomical algorithms for automated analysis of tissue protein expression in breast cancer
por: Ali, H R, et al.
Publicado: (2013)

Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer
por: Morrison, D H, et al.
Publicado: (2012)

Circulating cell-free miRNAs as biomarker for triple-negative breast cancer
por: Shin, V Y, et al.
Publicado: (2015)

Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers
por: Green, A R, et al.
Publicado: (2013)

Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion
por: Fry, Simon A, et al.
Publicado: (2016)

PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer
por: Munkácsy, G, et al.
Publicado: (2010)

Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole
por: Miller, W R, et al.
Publicado: (2006)

Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
por: Seo, A N, et al.
Publicado: (2013)

c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays
por: Garcia, S, et al.
Publicado: (2007)

NT5E CpG island methylation is a favourable breast cancer biomarker
por: Lo Nigro, C, et al.
Publicado: (2012)

BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses
por: Papadakis, E S, et al.
Publicado: (2017)

Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples
por: Kazarian, Anna, et al.
Publicado: (2017)

Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response
por: Al-kaabi, M M, et al.
Publicado: (2015)

In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery
por: Zhang, Jian, et al.
Publicado: (2017)

Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer
por: Aleskandarany, Mohammed A, et al.
Publicado: (2017)

Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics
por: Wang, W, et al.
Publicado: (2014)

The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer
por: Al-Saad, S, et al.
Publicado: (2008)

High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer
por: İlie, M, et al.
Publicado: (2010)

Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy
por: Fujii, Takeo, et al.
Publicado: (2017)

Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer
por: Nalwoga, H, et al.
Publicado: (2010)

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53
por: Millar, E K A, et al.
Publicado: (2011)

Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer
por: Wang, M, et al.
Publicado: (2014)

The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer
por: Mohammed, Z M A, et al.
Publicado: (2013)

SNIP/p140Cap mRNA expression is an unfavourable prognostic factor in breast cancer and is not expressed in normal breast tissue
por: Kennedy, S, et al.
Publicado: (2008)

Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients
por: Panse, J, et al.
Publicado: (2008)

Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction
por: Baneshi, M R, et al.
Publicado: (2010)

Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays
por: Akbar, Shazia, et al.
Publicado: (2015)

Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer
por: Cocco, E, et al.
Publicado: (2009)

DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers
por: Kotsopoulos, J, et al.
Publicado: (2007)

Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays
por: Prowatke, I, et al.
Publicado: (2007)

The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis
por: Gee, H E, et al.
Publicado: (2011)

Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease
por: Bluff, J E, et al.
Publicado: (2009)

Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer
por: Dive, C, et al.
Publicado: (2010)

Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis?
por: Woei-A-Jin, F J Sherida H, et al.
Publicado: (2016)

BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival
por: Hugdahl, Emilia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_iu406njho6ettmdgcdkoqmouq1